Form 4: Sanara MedTech CEO Adjusts Holdings
Statement of Changes in Beneficial Ownership
Sanara MedTech CEO Seth D. Yon reported a transaction involving the withholding of shares for tax obligations.
Summary
- Seth D. Yon, CEO and Director of Sanara MedTech Inc., engaged in a transaction on May 15, 2026.
- This transaction involved the withholding of 3,852 shares of common stock to cover tax obligations related to the annual vesting of 13,466 restricted stock units.
- No new shares were issued or sold; the withheld shares were used to satisfy tax liabilities.
- The value assigned to the withheld shares was $21.06 per share, reflecting the market price on the vesting date.
- Following this transaction, Mr. Yon beneficially owns 109,546 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it represents a routine tax-related transaction for an executive rather than a strategic move or a reflection of the company's performance.
Positives
- The CEO continues to hold a significant direct beneficial ownership of 109,546 shares, indicating continued commitment.
- The transaction was a standard procedure for satisfying tax withholding obligations, not a sale of shares by the executive.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, which details a change in beneficial ownership due to tax withholding.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and are crucial for understanding executive alignment with shareholder interests. The withholding of shares for tax purposes is a common practice upon vesting of restricted stock.
Stakeholder Impact
- Shareholders: The transaction does not involve a sale of shares by the CEO, thus not directly impacting the supply of shares in the market. Continued direct ownership by the CEO may be viewed positively.
- Employees: The transaction is related to executive compensation and tax obligations, with no direct impact on other employees.
- Management: The CEO's tax obligations are being met through a standard procedure.
Key Dates
| Date | Description |
|---|---|
| 05/15/2026 | Earliest transaction date and transaction date for withholding of shares. |
| 05/18/2026 | Date of signature for the filing. |
Keywords
Sanara MedTech Inc., SMTI, Form 4, Beneficial Ownership, Stock Withholding, Tax Obligations, Restricted Stock, Executive Compensation, Seth D. Yon
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.